$CCCS
CCC Intelligent Solutions Holdings Inc.

2024 Q2 Form 10-Q Financial Statement

#000095017024050638 Filed on April 30, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1
Revenue $232.6M $227.2M
YoY Change 9.88% 10.89%
Cost Of Revenue $55.32M $59.38M
YoY Change -5.75% 3.93%
Gross Profit $177.3M $167.9M
YoY Change 15.87% 13.58%
Gross Profit Margin 76.22% 73.87%
Selling, General & Admin $87.59M $92.65M
YoY Change 6.72% 22.88%
% of Gross Profit 49.4% 55.19%
Research & Development $49.25M $49.48M
YoY Change 13.58% 20.69%
% of Gross Profit 27.78% 29.47%
Depreciation & Amortization $29.75M $33.95M
YoY Change -11.0% -0.02%
% of Gross Profit 16.78% 20.23%
Operating Expenses $154.8M $160.1M
YoY Change 7.89% 19.04%
Operating Profit $22.51M $7.797M
YoY Change 135.61% -41.5%
Interest Expense $16.60M $16.45M
YoY Change -360.3% 18.94%
% of Operating Profit 73.74% 211.0%
Other Income/Expense, Net $1.253M $2.939M
YoY Change -106.25% 5342.59%
Pretax Income $25.75M -$4.834M
YoY Change -125.85% -445.04%
Income Tax $4.300M -$4.200M
% Of Pretax Income 16.7%
Net Earnings $21.45M -$597.0K
YoY Change -121.96% -127.34%
Net Earnings / Revenue 9.22% -0.26%
Basic Earnings Per Share $0.03 $0.00
Diluted Earnings Per Share $0.03 $0.00
COMMON SHARES
Basic Shares Outstanding 614.6M 604.7M
Diluted Shares Outstanding 638.4M 598.3M

Balance Sheet

Concept 2024 Q2 2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $237.9M $191.2M
YoY Change -41.05% -43.49%
Cash & Equivalents $237.9M $191.2M
Short-Term Investments
Other Short-Term Assets $26.59M $31.29M
YoY Change -42.34% -9.99%
Inventory
Prepaid Expenses
Receivables $120.9M $102.0M
Other Receivables $4.093M $0.00
Total Short-Term Assets $408.9M $343.2M
YoY Change -25.87% -29.25%
LONG-TERM ASSETS
Property, Plant & Equipment $176.4M $164.8M
YoY Change -4.75% 9.52%
Goodwill $1.418B $1.418B
YoY Change 0.0% -5.18%
Intangibles $970.5M $990.5M
YoY Change -8.79% -9.46%
Long-Term Investments $10.23M $10.23M
YoY Change 0.0% 0.0%
Other Assets $42.55M $43.70M
YoY Change -42.14% -15.58%
Total Long-Term Assets $2.670B $2.680B
YoY Change -2.93% -6.16%
TOTAL ASSETS
Total Short-Term Assets $408.9M $343.2M
Total Long-Term Assets $2.670B $2.680B
Total Assets $3.079B $3.024B
YoY Change -6.76% -9.51%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $20.95M $23.72M
YoY Change 9.8% 50.16%
Accrued Expenses $61.15M $39.50M
YoY Change -0.99% -14.07%
Deferred Revenue $45.99M $45.25M
YoY Change 14.79% 12.37%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $8.000M $8.000M
YoY Change -27.05% 0.0%
Total Short-Term Liabilities $146.6M $135.8M
YoY Change 8.28% 8.87%
LONG-TERM LIABILITIES
Long-Term Debt $764.2M $765.9M
YoY Change -4.47% -0.85%
Other Long-Term Liabilities $10.35M $7.347M
YoY Change -90.55% 272.0%
Total Long-Term Liabilities $774.6M $773.2M
YoY Change -14.84% -0.16%
TOTAL LIABILITIES
Total Short-Term Liabilities $146.6M $135.8M
Total Long-Term Liabilities $774.6M $773.2M
Total Liabilities $1.167B $1.222B
YoY Change -8.68% -2.42%
SHAREHOLDERS EQUITY
Retained Earnings -$1.106B -$1.127B
YoY Change 37.67% 59.69%
Common Stock $62.00K $61.00K
YoY Change -1.59% -3.17%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.894B $1.784B
YoY Change
Total Liabilities & Shareholders Equity $3.079B $3.024B
YoY Change -6.76% -9.51%

Cashflow Statement

Concept 2024 Q2 2024 Q1
OPERATING ACTIVITIES
Net Income $21.45M -$597.0K
YoY Change -121.96% -127.34%
Depreciation, Depletion And Amortization $29.75M $33.95M
YoY Change -11.0% -0.02%
Cash From Operating Activities $51.77M $55.24M
YoY Change -25.56% 66.98%
INVESTING ACTIVITIES
Capital Expenditures $15.56M $15.66M
YoY Change 6.95% 7.77%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$15.56M -$15.66M
YoY Change 6.95% 7.77%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $2.000M
YoY Change 0.0%
Cash From Financing Activities 10.52M -43.85M
YoY Change -1.03% 992.35%
NET CHANGE
Cash From Operating Activities 51.77M 55.24M
Cash From Investing Activities -15.56M -15.66M
Cash From Financing Activities 10.52M -43.85M
Net Change In Cash 46.73M -4.384M
YoY Change -28.8% -130.1%
FREE CASH FLOW
Cash From Operating Activities $51.77M $55.24M
Capital Expenditures $15.56M $15.66M
Free Cash Flow $36.21M $39.57M
YoY Change -34.16% 113.4%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001818201
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
CCC INTELLIGENT SOLUTIONS HOLDINGS INC.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity File Number
EntityFileNumber
001-39447
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1546280
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
167 N. Green Street
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
9th Floor
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Chicago
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60607
CY2024Q1 dei City Area Code
CityAreaCode
800
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
621-8070
CY2024Q1 dei Security12b Title
Security12bTitle
Common stock, par value $0.0001 per share
CY2024Q1 dei Trading Symbol
TradingSymbol
CCCS
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
614584238
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
191188000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
195572000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4792000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5574000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
102007000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
102365000
CY2024Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
0
CY2023Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
1798000
CY2024Q1 us-gaap Deferred Costs Current
DeferredCostsCurrent
18693000
CY2023Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
17900000
CY2024Q1 us-gaap Other Assets Current
OtherAssetsCurrent
31294000
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
32364000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
343182000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
349999000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
164825000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
160416000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
30486000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
30456000
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
990537000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1015046000
CY2024Q1 us-gaap Goodwill
Goodwill
1417724000
CY2023Q4 us-gaap Goodwill
Goodwill
1417724000
CY2024Q1 cccs Deferred Financing Fees Revolver Net Non Current
DeferredFinancingFeesRevolverNetNonCurrent
1518000
CY2023Q4 cccs Deferred Financing Fees Revolver Net Non Current
DeferredFinancingFeesRevolverNetNonCurrent
1672000
CY2024Q1 us-gaap Deferred Costs
DeferredCosts
21460000
CY2023Q4 us-gaap Deferred Costs
DeferredCosts
22302000
CY2024Q1 us-gaap Equity Method Investments
EquityMethodInvestments
10228000
CY2023Q4 us-gaap Equity Method Investments
EquityMethodInvestments
10228000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
43700000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
43197000
CY2024Q1 us-gaap Assets
Assets
3023660000
CY2023Q4 us-gaap Assets
Assets
3051040000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
23718000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
16324000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
39503000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
71478000
CY2024Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
9126000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
3689000
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
8000000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
8000000
CY2024Q1 cccs Long Term Licensing Agreement Net Current
LongTermLicensingAgreementNetCurrent
3109000
CY2023Q4 cccs Long Term Licensing Agreement Net Current
LongTermLicensingAgreementNetCurrent
3061000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7136000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6788000
CY2024Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
45254000
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
43567000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
135846000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
152907000
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
765874000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
767504000
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
183310000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
195365000
CY2024Q1 cccs Long Term Licensing Agreement Net Non Current
LongTermLicensingAgreementNetNonCurrent
26896000
CY2023Q4 cccs Long Term Licensing Agreement Net Non Current
LongTermLicensingAgreementNetNonCurrent
27692000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
50066000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
50796000
CY2024Q1 cccs Warrant Liablity
WarrantLiablity
53086000
CY2023Q4 cccs Warrant Liablity
WarrantLiablity
51501000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7347000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6414000
CY2024Q1 us-gaap Liabilities
Liabilities
1222425000
CY2023Q4 us-gaap Liabilities
Liabilities
1252179000
CY2024Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
17726000
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
16584000
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
5000000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
614257735
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
614257735
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
603128781
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
603128781
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
61000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
60000
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2911660000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2909757000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1127064000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1126467000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1148000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1073000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1783509000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1782277000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3023660000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3051040000
CY2024Q1 us-gaap Revenues
Revenues
227237000
CY2023Q1 us-gaap Revenues
Revenues
204919000
CY2024Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
52808000
CY2023Q1 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
50447000
CY2024Q1 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
6567000
CY2023Q1 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
6685000
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
59375000
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
57132000
CY2024Q1 us-gaap Gross Profit
GrossProfit
167862000
CY2023Q1 us-gaap Gross Profit
GrossProfit
147787000
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
49477000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
40996000
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
35586000
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
33531000
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
57060000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41865000
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
17942000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
18066000
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
160065000
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
134458000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
7797000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
13329000
CY2024Q1 us-gaap Interest Expense
InterestExpense
16452000
CY2023Q1 us-gaap Interest Expense
InterestExpense
13832000
CY2024Q1 us-gaap Interest Income Operating
InterestIncomeOperating
2467000
CY2023Q1 us-gaap Interest Income Operating
InterestIncomeOperating
3259000
CY2024Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1585000
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1195000
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2939000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2550000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4834000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1401000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4237000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-783000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-597000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2184000
CY2024Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
1142000
CY2023Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
0
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1739000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2184000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
598279377
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
616217176
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
598279377
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
646380961
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-597000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
2184000
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-75000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
34000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-672000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
2218000
CY2024Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
1142000
CY2023Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
0
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1814000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2218000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1782277000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
44971000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense
8822000
CY2024Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1833000
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
-52580000
CY2024Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
1142000
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-75000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-597000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1783509000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
2045287000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
28930000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense
8243000
CY2023Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1326000
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
-11449000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
34000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
2184000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
2074555000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
-597000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
2184000
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9442000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9206000
CY2024Q1 cccs Amortization Of Intangible Asset
AmortizationOfIntangibleAsset
24509000
CY2023Q1 cccs Amortization Of Intangible Asset
AmortizationOfIntangibleAsset
24751000
CY2024Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-12055000
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-6763000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
44971000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
29234000
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
462000
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
427000
CY2024Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
62000
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
56000
CY2024Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
718000
CY2023Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-2604000
CY2024Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1585000
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1195000
CY2024Q1 cccs Noncash Lease Expense
NoncashLeaseExpense
0
CY2023Q1 cccs Noncash Lease Expense
NoncashLeaseExpense
942000
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-253000
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
195572000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
323788000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
191188000
CY2024Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-71000
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-58000
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-370000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-6084000
CY2024Q1 cccs Increase Decrease In Deferred Costs Current
IncreaseDecreaseInDeferredCostsCurrent
793000
CY2023Q1 cccs Increase Decrease In Deferred Costs Current
IncreaseDecreaseInDeferredCostsCurrent
783000
CY2024Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-992000
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-1726000
CY2024Q1 cccs Increase Decrease In Deferred Costs Non Current
IncreaseDecreaseInDeferredCostsNonCurrent
-842000
CY2023Q1 cccs Increase Decrease In Deferred Costs Non Current
IncreaseDecreaseInDeferredCostsNonCurrent
51000
CY2024Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-144000
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
8519000
CY2024Q1 cccs Increase Decrease In Operating Lease Assets
IncreaseDecreaseInOperatingLeaseAssets
710000
CY2023Q1 cccs Increase Decrease In Operating Lease Assets
IncreaseDecreaseInOperatingLeaseAssets
417000
CY2024Q1 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
7235000
CY2023Q1 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
5778000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
7395000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-11897000
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-31153000
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-25690000
CY2024Q1 cccs Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
298000
CY2023Q1 cccs Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
415000
CY2024Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1697000
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
5033000
CY2024Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
933000
CY2023Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-105000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
55235000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
33078000
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15663000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14534000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-15663000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-14534000
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8901000
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8109000
CY2024Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
1833000
CY2023Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
1326000
CY2024Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
52581000
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
11449000
CY2024Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2000000
CY2023Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2000000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-43847000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4014000
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-109000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
36000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4384000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
14566000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
338354000
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
646000
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
626000
CY2024Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
15908000
CY2023Q1 us-gaap Paid In Kind Interest
PaidInKindInterest
13446000
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
576000
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
202000
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Use of Estimates</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">—The </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">preparation of the condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts, and the disclosures of contingent amounts, in the Company’s condensed consolidated financial statements and the accompanying notes. Although the Company regularly assesses these estimates, actual</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">results </span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">could differ from those estimates. Changes in estimates are recorded in the period in which they become known. The Company bases its estimates on historical experience and various other assumptions that it believes to be reasonable under the circumstances. Actual results could differ from management’s estimates if past experience or other assumptions are not substantially accurate. Significant estimates in these condensed consolidated financial statements include the estimation of contract transaction prices, the determination of the amortization period for contract assets, the valuation of goodwill and intangible assets, the valuation of the warrant liabilities, and the estimates and assumptions associated with stock incentive plans.</span>
CY2024Q1 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="margin-left:4.533%;font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Reclassifications</span><span style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">—</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Certain reclassifications of prior period amounts have been made to conform to the current period presentation. For the three months ended March 31, 2024, changes in the fair value of the Company's interest rate cap agreements are recognized within other income (expense)—net in the condensed consolidated statements of operations and comprehensive (loss) income. Corresponding amounts recognized during the three months ended March 31, 2023, were previously classified as a change in fair value of derivative instruments and have been reclassified to conform to the current period presentation. The amounts reclassified had no impact on net (loss) income</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">.</span></p>
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
227237000
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
204919000
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
1533000000
CY2024Q1 cccs Revenue Remaining Performance Obligation Revenue To Be Recognized Year One
RevenueRemainingPerformanceObligationRevenueToBeRecognizedYearOne
617000000
CY2024Q1 cccs Revenue Remaining Performance Obligation Revenue To Be Recognized Thereafter
RevenueRemainingPerformanceObligationRevenueToBeRecognizedThereafter
916000000
CY2024Q1 cccs Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
39000000
CY2023Q1 cccs Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
33800000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
102007000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
102365000
CY2024Q1 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
18693000
CY2023Q4 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
17900000
CY2024Q1 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
21460000
CY2023Q4 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
22302000
CY2024Q1 us-gaap Contract With Customer Asset Gross Noncurrent
ContractWithCustomerAssetGrossNoncurrent
15726000
CY2023Q4 us-gaap Contract With Customer Asset Gross Noncurrent
ContractWithCustomerAssetGrossNoncurrent
15198000
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
45254000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
43567000
CY2024Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2306000
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1373000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
44940000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
36479000
CY2024Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-115413000
CY2023Q1 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-103187000
CY2024Q1 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
118033000
CY2023Q1 us-gaap Contract With Customer Liability Cumulative Catch Up Adjustment To Revenue Change In Measure Of Progress
ContractWithCustomerLiabilityCumulativeCatchUpAdjustmentToRevenueChangeInMeasureOfProgress
108130000
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
47560000
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
41422000
CY2024Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
45254000
CY2023Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
40272000
CY2024Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2306000
CY2023Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
1150000
CY2024Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
47560000
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
41422000
CY2023Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
40202000
CY2022Q4 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
36717000
CY2024Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
-5249000
CY2023Q1 us-gaap Capitalized Contract Cost Amortization
CapitalizedContractCostAmortization
-4785000
CY2024Q1 cccs Capitalized Contract Cost Additional Amounts Deferred
CapitalizedContractCostAdditionalAmountsDeferred
5200000
CY2023Q1 cccs Capitalized Contract Cost Additional Amounts Deferred
CapitalizedContractCostAdditionalAmountsDeferred
5619000
CY2024Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
40153000
CY2023Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
37551000
CY2024Q1 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
18693000
CY2023Q1 us-gaap Capitalized Contract Cost Net Current
CapitalizedContractCostNetCurrent
17339000
CY2024Q1 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
21460000
CY2023Q1 us-gaap Capitalized Contract Cost Net Noncurrent
CapitalizedContractCostNetNoncurrent
20212000
CY2024Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
40153000
CY2023Q1 us-gaap Capitalized Contract Cost Net
CapitalizedContractCostNet
37551000
CY2024Q1 cccs Discount Rate Based On Cost Of Debt
DiscountRateBasedOnCostOfDebt
0.10
CY2024Q1 cccs Increase Decrease In Contingent Consideration Liability
IncreaseDecreaseInContingentConsiderationLiability
0
CY2023Q1 cccs Increase Decrease In Contingent Consideration Liability
IncreaseDecreaseInContingentConsiderationLiability
0
CY2024Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4200000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-800000
CY2024Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
576000
CY2023Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
224000
CY2024Q1 us-gaap Accounts Receivable Gross
AccountsReceivableGross
106799000
CY2023Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
107939000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4792000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5574000
CY2024Q1 us-gaap Accounts Receivable Net
AccountsReceivableNet
102007000
CY2023Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
102365000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5574000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
5339000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
964000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
3136000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1746000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
1609000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
4792000
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6866000
CY2024Q1 cccs Prepaid Saas Costs
PrepaidSaasCosts
8228000
CY2023Q4 cccs Prepaid Saas Costs
PrepaidSaasCosts
7833000
CY2024Q1 cccs Prepaid Service Fee
PrepaidServiceFee
7139000
CY2023Q4 cccs Prepaid Service Fee
PrepaidServiceFee
5992000
CY2024Q1 cccs Prepaid Software And Equipment Maintenance
PrepaidSoftwareAndEquipmentMaintenance
4074000
CY2023Q4 cccs Prepaid Software And Equipment Maintenance
PrepaidSoftwareAndEquipmentMaintenance
5547000
CY2024Q1 us-gaap Prepaid Insurance
PrepaidInsurance
1264000
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
2289000
CY2024Q1 us-gaap Other Assets
OtherAssets
10589000
CY2023Q4 us-gaap Other Assets
OtherAssets
10703000
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
31294000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
72454000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
32364000
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
293886000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
285418000
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
129061000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
125002000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
164825000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
160416000
CY2024Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
9400000
CY2023Q1 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
9200000
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1408000
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
1503000
CY2024Q1 us-gaap Variable Lease Cost
VariableLeaseCost
1101000
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
884000
CY2024Q1 us-gaap Lease Cost
LeaseCost
2509000
CY2023Q1 us-gaap Lease Cost
LeaseCost
2387000
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1800000
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
900000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
72454000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
72454000
CY2024Q1 cccs Finite Lived Intangible Assets Amortization Expense After Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
453992000
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
700000
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
CY2024Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2024Q1 us-gaap Goodwill Gross
GoodwillGross
1520926000
CY2024Q1 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
103202000
CY2024Q1 us-gaap Goodwill
Goodwill
1417724000
CY2023Q4 us-gaap Goodwill Gross
GoodwillGross
1520926000
CY2023Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
103202000
CY2023Q4 us-gaap Goodwill
Goodwill
1417724000
CY2023 us-gaap Asset Impairment Charges
AssetImpairmentCharges
77400000
CY2019 us-gaap Asset Impairment Charges
AssetImpairmentCharges
25800000
CY2024Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2023Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2024Q1 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2023Q1 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1476470000
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-676403000
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
800067000
CY2024Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1666940000
CY2024Q1 cccs Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
676403000
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
990537000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1476470000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-651894000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
824576000
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1666940000
CY2023Q4 cccs Intangible Assets Accumulated Amortization
IntangibleAssetsAccumulatedAmortization
651894000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1015046000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
56259000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
72454000
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
800067000
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
20571000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
54593000
CY2024Q1 cccs Accrued Royalties And Licenses Current
AccruedRoyaltiesAndLicensesCurrent
4076000
CY2023Q4 cccs Accrued Royalties And Licenses Current
AccruedRoyaltiesAndLicensesCurrent
4381000
CY2024Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
4060000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2183000
CY2024Q1 cccs Accrued Sales Tax Current
AccruedSalesTaxCurrent
3267000
CY2023Q4 cccs Accrued Sales Tax Current
AccruedSalesTaxCurrent
2968000
CY2024Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
3107000
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
2572000
CY2024Q1 cccs Software License Agreement Current
SoftwareLicenseAgreementCurrent
1423000
CY2023Q4 cccs Software License Agreement Current
SoftwareLicenseAgreementCurrent
2233000
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2999000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2548000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
39503000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
71478000
CY2023Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
14179000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
282656000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
32391014
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
2.99
CY2024Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
3937000
CY2023Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
3937000
CY2024Q1 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
2306000
CY2023Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1373000
CY2024Q1 cccs Software License Agreement Noncurrent
SoftwareLicenseAgreementNoncurrent
1004000
CY2023Q4 cccs Software License Agreement Noncurrent
SoftwareLicenseAgreementNoncurrent
1004000
CY2024Q1 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
100000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability
BusinessCombinationContingentConsiderationLiability
100000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7347000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
6414000
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
8000000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
8000000
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
765874000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
767504000
CY2020Q1 cccs Percentage Of Compound Interest Per Annum On The Preferred Share Issue Price
PercentageOfCompoundInterestPerAnnumOnThePreferredShareIssuePrice
0.10
CY2023Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
16584000
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
14179000
CY2024Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
1142000
CY2023Q1 us-gaap Temporary Equity Accretion To Redemption Value
TemporaryEquityAccretionToRedemptionValue
0
CY2024Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
17726000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
2.92
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
32436762
CY2024Q1 cccs Share Based Compensation By Share Based Payment Award Non Vested Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationByShareBasedPaymentAwardNonVestedOptionsOutstandingWeightedAverageExercisePrice
3
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q1 cccs Shares Authorized Total
SharesAuthorizedTotal
5000000000
CY2024Q1 us-gaap Common Stock Voting Rights
CommonStockVotingRights
one
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
614257735
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
614257735
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
603128781
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
603128781
CY2024Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
22000000
CY2024Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
49450000
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms
(i) the extension of the performance period by one year, (ii) a change to the performance criteria, (iii) a change to the number of units to be issued depending on performance and (iv) for certain grants, imposing a maximum number of units to be issued depending on performance equal to 100% of the target.The modification to the performance-based RSUs subject to a market condition resulted in incremental stock-based compensation expense of $67.0 million, which is being recognized ratably over the modified performance periods.
CY2023 cccs Percentage Of Number Of Units To Be Issued Depending On Performance
PercentageOfNumberOfUnitsToBeIssuedDependingOnPerformance
1
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
35788469
CY2023Q4 cccs Share Based Compensation By Share Based Payment Award Non Vested Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationByShareBasedPaymentAwardNonVestedOptionsOutstandingWeightedAverageExercisePrice
296
CY2023 cccs Share Based Compensation By Share Based Arrangement Non Vested Options Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationByShareBasedArrangementNonVestedOptionsOutstandingWeightedAverageRemainingContractualTerm
P4Y
CY2023Q4 cccs Share Based Compensation By Share Based Arrangement Non Vested Options Outstanding Aggregate Intrinsic Value
ShareBasedCompensationByShareBasedArrangementNonVestedOptionsOutstandingAggregateIntrinsicValue
301563000
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
3346599
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.64
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares
5108
CY2024Q1 cccs Share Based Compensation By Share Based Arrangement Non Vested Options Outstanding Weighted Average Remaining Contractual Term
ShareBasedCompensationByShareBasedArrangementNonVestedOptionsOutstandingWeightedAverageRemainingContractualTerm
P3Y9M18D
CY2024Q1 cccs Share Based Compensation By Share Based Arrangement Non Vested Options Outstanding Aggregate Intrinsic Value
ShareBasedCompensationByShareBasedArrangementNonVestedOptionsOutstandingAggregateIntrinsicValue
290713000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
31152178
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
2.89
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y8M12D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P3Y9M18D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
290472000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
1300000
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
86900000
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y6M
CY2024Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.5
CY2024Q1 us-gaap Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable
ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
2021-08-29
CY2024Q1 cccs Class Of Warrant Or Rights Date From Which Warrants Or Rights Exercisable Expired
ClassOfWarrantOrRightsDateFromWhichWarrantsOrRightsExercisableExpired
2026-07-30
CY2024Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1600000
CY2023Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1200000
CY2024Q1 cccs Warrant Liablity
WarrantLiablity
53100000
CY2023Q4 cccs Warrant Liablity
WarrantLiablity
51500000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-597000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
2184000
CY2024Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
1142000
CY2023Q1 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
0
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1739000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
2184000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
598279377
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
616217176
CY2024Q1 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
0
CY2023Q1 us-gaap Amount Of Dilutive Securities Stock Options And Restrictive Stock Units
AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits
30163785000
CY2024Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
718000
CY2023Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-2604000
CY2024Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
2031000
CY2023Q1 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0
CY2024Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
190000
CY2023Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
54000
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2939000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2550000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
598279377
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
646380961
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
36824894
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15957331
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2024Q1 us-gaap Revenues
Revenues
227237000
CY2023Q1 us-gaap Revenues
Revenues
204919000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
164825000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
160416000
CY2024Q1 ecd Trd Arr Ind Name
TrdArrIndName
Mary Jo Prigge
CY2024Q1 ecd Trd Arr Ind Title
TrdArrIndTitle
Executive Vice President, Chief Service Delivery Officer of the Company
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
true
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
true
CY2024Q1 ecd Trd Arr Adoption Date
TrdArrAdoptionDate
March 20, 2024
CY2024Q1 ecd Trd Arr Securities Agg Avail Amt
TrdArrSecuritiesAggAvailAmt
200000

Files In Submission

Name View Source Status
0000950170-24-050638-index-headers.html Edgar Link pending
0000950170-24-050638-index.html Edgar Link pending
0000950170-24-050638.txt Edgar Link pending
0000950170-24-050638-xbrl.zip Edgar Link pending
cccs-20240331.htm Edgar Link pending
cccs-20240331.xsd Edgar Link pending
cccs-ex31_1.htm Edgar Link pending
cccs-ex31_2.htm Edgar Link pending
cccs-ex32_1.htm Edgar Link pending
cccs-ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
cccs-20240331_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending